SCHEMBL10816337

SCHEMBL10816337

CCCCCCCCCCOC(=O)OCCCOC(OC(=O)OCCCCCCCCCC)n1cnc2c(SC)ncnc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ CYP3A4 P08684 6/20 0.36
▸ ADA P00813 4/20 0.36
▸ PDE2A O00408 3/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ CCNB2 O95067 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CCNB1 P14635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10814393 0.86 HK1 (0.39) CYP3A4ALDH1A1CDK1CCNB1CYP2D6
SCHEMBL10816711 0.85 CYP1A2 (0.37) CYP1A2TSHRCYP3A4ADAPDE2A
SCHEMBL10815169 0.85 ALDH1A1 (0.31) CYP1A2TSHRALDH1A1
SCHEMBL10814378 0.84 CCNB2 (0.43) CYP1A2TSHRCYP3A4ADAPDE2A
SCHEMBL9583624 0.83 CYP1A2 (0.40) CYP1A2TSHRSMN1; SMN2CCNB2CDK1
SCHEMBL10817431 0.82 ADA (0.47) CYP1A2TSHRCYP3A4ADAPDE2A
SCHEMBL10816341 0.77 CYP1A2 (0.51) CYP1A2TSHRCYP3A4ALDH1A1CYP2D6
SCHEMBL10817760 0.75 CYP1A2 (0.48) CYP1A2TSHRCYP3A4ALDH1A1SMN1; SMN2
SCHEMBL10813829 0.74 ADORA2A (0.45) CYP1A2TSHRCYP3A4ADAPDE2A
SCHEMBL9583296 0.69 CYP1A2 (0.46) CYP1A2TSHRCYP3A4ADAPDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0105135-B1 SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS SYNTEX (U.S.A.) INC. (US) 1987-03-18 — — EP disclosed
Send feedback